-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Reiterates Overweight on Amgen, Maintains $328 Price Target

Benzinga·06/27/2025 16:15:16
Listen to the news
Piper Sandler analyst David Amsellem reiterates Amgen (NASDAQ:AMGN) with a Overweight and maintains $328 price target.